000 | 01918 a2200517 4500 | ||
---|---|---|---|
005 | 20250515132006.0 | ||
264 | 0 | _c20090807 | |
008 | 200908s 0 0 eng d | ||
022 | _a1435-4373 | ||
024 | 7 |
_a10.1007/s10096-008-0600-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMachala, L | |
245 | 0 | 0 |
_aAntibody response of HIV-infected patients to latent, cerebral and recently acquired toxoplasmosis. _h[electronic resource] |
260 |
_bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _cFeb 2009 |
||
300 |
_a179-82 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Retroviral Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntibodies, Protozoan _xblood |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aComplement Fixation Tests |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHIV Infections _xcomplications |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aImmunoglobulin M _xblood |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aToxoplasma _xisolation & purification |
650 | 0 | 4 |
_aToxoplasmosis _xcomplications |
650 | 0 | 4 |
_aToxoplasmosis, Cerebral _xcomplications |
700 | 1 | _aMalý, M | |
700 | 1 | _aHrdá, S | |
700 | 1 | _aRozsypal, H | |
700 | 1 | _aStanková, M | |
700 | 1 | _aKodym, P | |
773 | 0 |
_tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology _gvol. 28 _gno. 2 _gp. 179-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10096-008-0600-9 _zAvailable from publisher's website |
999 |
_c18163087 _d18163087 |